Name: XBIT Balance Sheet - Xbiotech Assets & Debt | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Total Assets, Current Assets, Cash and Equivalents, Total Liabilities, Long-term Debt, Short-term Debt, Shareholders Equity, Working Capital, Book Value Per Share

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

XBIT - Xbiotech Inc.

USD | NASDAQ | Healthcare

XBIT Balance Sheet - Xbiotech Assets & Debt | Ledgeburg

(in millions of USD)	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012
Cash And Short Term Investments
Cash And Equivalents	125.6	172.7	200.0	157.3	237.0	237.4	714.6	15.8	31.8	34.3	91.1	57.3	7.2	4.2
Restricted Cash	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Short Term Investments	-	-	0.0	60.2	0.0	-	-	-	-	-	-	-	-	-
Cash And Short Term Investments	125.6	172.7	200.0	217.5	237.0	237.4	714.6	15.8	31.8	34.3	91.1	57.3	7.2	4.2
Receivables
Accounts Receivable	-	-	-	-	0.0	4.1	0.0	-	-	-	-	-	-	-
Current Assets
Inventory	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid Expenses
Non-Current Assets
Property, Plant & Equipment Gross	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Current Liabilities
Accounts Payable	1.5	2.2	2.5	2.4	2.1	2.5	2.1	1.7	1.7	4.4	4.8	1.6	-	-
Short Term Debt
Non-Current Liabilities
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Liabilities Non-Current
Common Equity
Common Stock	276.7	273.1	271.2	267.3	262.3	249.8	324.8	279.4	277.5	242.4	233.9	152.4	-	-
Additional Paid In Capital
Supplementary Data
Total Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net debt

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q2 FY 19	Q1 FY 19	Q4 FY 18	Q3 FY 18	Q2 FY 18	Q1 FY 18	Q4 FY 17	Q3 FY 17	Q2 FY 17	Q1 FY 17	Q4 FY 16	Q3 FY 16	Q2 FY 16
Cash And Short Term Investments
Cash And Equivalents	115.5	125.6	147.4	152.9	155.9	172.7	183.1	188.5	201.0	200.0	202.2	143.4	152.5	157.3	160.6

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Receivables
Accounts Receivable	-	-	0.5	0.5	0.5	0.7	0.7	0.9	0.9	0.9	0.9	-	-	1.2	1.5	-	0.5	0.0	0.0	0.0	1.7	4.1	6.1	20.7	9.7	0.0	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Current Assets
Inventory	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid Expenses	1.3	1.0	1.1	1.3	1.2	1.0	1.0	1.1	1.1	0.8	0.9	0.9	0.7	0.6	0.6	0.5	0.6	0.9
Other Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Assets Held For Sale	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Assets	117.0	127.0	149.0	154.9	157.7	174.6	185.0	190.6	203.1	201.7	204.4	209.5	216.3	219.8	223.4	238.8

Non-Current Assets
Property, Plant & Equipment Gross	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accumulated Depreciation	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Property,Plant & Equipment Net	22.8	23.1	23.5	23.8	24.2	24.5	24.8	24.9	24.8	24.9	25.2	25.6	25.8	26.3	26.6	27.3
Long Term Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Equity Method Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Goodwill	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Intangible Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Right Of Use Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Tax Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.8	0.4	0.0	0.0
Other Non-Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non-Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	139.8	150.1	172.4	178.7	181.9	199.1	209.9	215.6	227.9	226.6	229.6	235.1	242.1	246.1	250.8	266.5	270.8

Non-Current Liabilities
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Liabilities Non-Current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue Non-Current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Tax Liabilities	0.0	0.0	-	-	-	-	-	-	-	-	0.0	0.0	0.0	0.1	0.9	0.9	0.9
Pension Obligations	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non-Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	4.8	9.7	5.3	5.6	7.2	16.8	17.7	18.9	18.6	7.8	6.9	6.1	5.2	5.7	6.0	10.7

Common Equity
Common Stock	276.9	276.7	276.6	276.5	276.4	273.1	272.4	272.0	271.6	271.2	269.9	268.9	268.0	267.3	266.3	265.2	263.7	262.3	260.9	256.8	255.5	249.8	251.8	246.4	242.9	324.8	320.1	319.0	280.7	279.4	278.9	278.4	277.8	277.5	277.1	276.6	276.1	242.4	238.8	237.5
Additional Paid In Capital	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	(141.9)	(136.4)	(109.5)	(103.5)	(101.7)	(90.8)	(80.3)	(75.3)	(62.3)	(52.3)	(47.7)	(40.3)	(31.6)	(27.7)	(24.5)	(11.9)	(0.2)
Accumulated Other Comprehensive Income	-	-	-	-	-	-	-	-	-	-	0.4	0.4	0.4	0.8	3.1	2.5
Treasury Stock	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Stockholders Equity	135.0	140.4	167.1	173.1	174.7	182.3	192.1	196.7	209.3	218.8	222.7	229.1	236.9	240.4	244.8	255.8	265.6
Total Equity	135.0	140.4	167.1	173.1	174.7	182.3	192.1	196.7	209.3	218.8	222.7	229.1	236.9	240.4	244.8	255.8	265.6	269.4